VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Friday, January 2, 2026
Stock Comparison
Pro Medicus Limited vs Sanofi
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Pro Medicus Limited
PME · ASX
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Pro Medicus Limited's moat claims, evidence, and risks.
View PME analysisSanofi
SAN · Euronext Paris
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: Pro Medicus Limited leads (80 / 100 vs 74 / 100 for Sanofi).
- Segment focus: Pro Medicus Limited has 2 segments (92.5% in Visage 7 Enterprise Imaging Platform (PACS / CloudPACS)); Sanofi has 3 segments (79.8% in Pharma (Prescription Medicines)).
- Primary market structure: Oligopoly vs Oligopoly. Pricing power: Strong vs Moderate.
- Moat breadth: Pro Medicus Limited has 6 moat types across 2 domains; Sanofi has 5 across 3.
Primary market context
Pro Medicus Limited
Visage 7 Enterprise Imaging Platform (PACS / CloudPACS)
Enterprise imaging / PACS and related modules for hospitals and integrated delivery networks (IDNs)
Primarily North America; also Europe and Australia
Hospitals, imaging centers, integrated delivery networks (IDNs)
Healthcare IT software vendor / platform provider
92.5%
Sanofi
Pharma (Prescription Medicines)
Branded prescription pharmaceuticals (immunology, rare disease, neurology, oncology, general medicines)
Global
Patients via payers/providers and channel partners (wholesalers, pharmacies, hospitals)
Research-based drug developer, manufacturer, and marketer
79.8%
Side-by-side metrics
Moat coverage
Shared moat types
No overlap yet.
Pro Medicus Limited strengths
Sanofi strengths
Segment mix
Pro Medicus Limited segments
Full profile >Visage 7 Enterprise Imaging Platform (PACS / CloudPACS)
Oligopoly
Visage RIS (Radiology Information System) and Promedicus.net
Oligopoly
Sanofi segments
Full profile >Pharma (Prescription Medicines)
Oligopoly
Vaccines
Oligopoly
Opella (Consumer Healthcare - Sanofi minority stake)
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.